ANTIDOTE Institute: How to Prepare a Specific Aims Page

Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
Continue

Prepare a Winning Specific Aims Page

The one page of Specific Aims is often the first part of an application that reviewers read. It serves as a critical component of research grant applications, providing a snapshot of the proposed research to funding agencies, reviewers, and stakeholders.

The ANTIDOTE Institute invites you to join our upcoming webinar on Monday, July 29th at 2pm ET for a special session on "How to Prepare a Specific Aims Page."

Through mentorship from established investigators in the field of medical toxicology, gain insight on how to craft a Specific Aims page that succinctly communicates the significance, innovation, and approach of your research project. Learn tips and tricks on best practices for setting a positive tone that engages reviewers and increases the likelihood of a favorable evaluation, advancing your research career.

Target Audience: open to the public, but specifically tailored for Fellows and Junior Faculty applying become part of the 2025 cohort of the ANTIDOTE Institute.
Format: Zoom Meeting
Length: 60 min

Have Questions?

Feel free to reach out to us at antidote.admin@acmt.net for any inquiries or clarifications. We look forward to assisting you on your journey with ANTIDOTE Institute!

About the ANTIDOTE Institute

The ANTIDOTE Institute is generously funded by NIH/NIDA (Grant No. 1R25DA058490) and presents a unique opportunity for fellows and junior faculty members to kickstart their journey in investigative research. Participants can expect to: begin cultivating their own research niche, build valuable connections with peers and seasoned investigators within their field, and acquire practical knowledge encompassing key aspects of establishing a successful research program. The institute spans two years and comprises:

Focused, small-group sessions featuring moderated peer review, mentorship, and in-depth discussions on fundamental research topics.

Personalized one-on-one mentorship with an accomplished medical toxicology investigator.

Furthermore, the program offers the potential for up to $25,000 in seed funding to bolster your research pursuits.

Interested in the Joining the ANTIDOTE Institute?

Find out about application deadlines and learn more at: www.acmt.net/antidote-institute

Stephanie Carreiro, MD, PhD, FACMT

Vice Chair of Research and Associate Professor of Emergency Medicine

University of Massachusetts Chan Medical School

Dr. Stephanie Carreiro is a physician-scientist at the forefront of digital health innovation in emergency medicine and medical toxicology. As an Associate Professor, Vice Chair of Research, and Director of the Tox(In)novation Lab at the University of Massachusetts Chan Medical School, she leads groundbreaking work that blends clinical expertise with cutting-edge technology to transform how we prevent, detect, and treat substance use disorders. Her research centers on digital phenotyping, digital therapeutics, and understanding how real-world patterns of technology use can inform interventions and promote health equity.

She earned her MD from New York Medical College in 2009, completed emergency medicine residency training at Brown University in 2013, and went on to complete a medical toxicology fellowship (2015) and a PhD in Biomedical Sciences (2022) at the University of Massachusetts. This foundation in both clinical medicine and biomedical research underpins her mission to develop practical, evidence-based digital solutions that improve patient outcomes and expand access to care.

Dr. Carreiro leads a diverse portfolio of industry-sponsored and federally funded research, including awards from the National Institute on Drug Abuse and the National Institute of Biomedical Imaging and Bioengineering. Across these projects, her goal is the same: to turn data into actionable insights, translate technology into real-world impact, and build digital tools that are as accessible as they are effective.

Peter Chai, MD, MMS

Associate Professor

Brigham and Women's Hospital

Dr. Peter R Chai is an associate professor of emergency medicine and medical toxicology at Brigham and Women’s Hospital/Harvard Medical School, and affiliate research scholar at the Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology, and The Fenway Institute. He is also research faculty at the Dana Farber Cancer Institute. Dr. Chai’s research primarily involves the development and implementation of technological solutions that detect and respond to changes in disease. These translational projects ranges from design of novel robotic and sensor systems in animal models to human clinical trials to test the implementation of injectable and ingestible sensor systems and overlying behavioral science architecture to respond to disease states. Specifically, Dr. Chai is interested in applying ingestible electronic sensor systems to understand medication adherence in the context of substance use and HIV treatment/prevention. His work in developing ingestible sensors and their overlying behavioral interventions as closed loop systems to measure, reinforce and provide tools for PrEP and ART adherence has been funded by the National Institutes of Health and industry partners.